Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9

...

Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval

August 07, 2025

Wegovy maker Novo Nordisk's sales hike in second quarter

August 06, 2025

Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers

August 05, 2025

Hims & Hers stock falls 10% on revenue miss

August 04, 2025

Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's

August 01, 2025

Trump's drug price ultimatum sets pharma firms scrambling

August 01, 2025

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

July 31, 2025

Trump's pharmaceutical tariffs could affect some drugmakers more than others

July 29, 2025

Shares of Novo Nordisk plunge 15% after Wegovy-maker cuts full-year guidance

July 29, 2025

Healthy Returns: Researchers move closer to a universal cancer vaccine

July 23, 2025

Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'

July 23, 2025

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

July 20, 2025

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

July 16, 2025

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

July 09, 2025

Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others

July 08, 2025

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground

June 25, 2025

5 things to know before the stock market opens Tuesday

June 24, 2025

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

June 23, 2025

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition

June 11, 2025

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

May 21, 2025

Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

May 19, 2025

Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price

May 16, 2025

Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down

May 15, 2025

Why Americans pay so much more for prescription drugs

May 14, 2025

Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance

May 07, 2025

Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat

May 07, 2025

How much a $1,000 investment in Hims & Hers at its IPO would be worth now

May 06, 2025

Hims & Hers brings former Amazon executive into C-suite

May 05, 2025

Cramer's week ahead: Earnings from Disney, Palantir and Uber

May 02, 2025

Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit

May 02, 2025

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.